Search

​On May 18, 2023, the Supreme Court unanimously affirmed the Federal Circuit's decision, Amgen Inc. v. Sanofi, 987 F.3d 1080 (Fed. Cir. 2021), that the claims of two of Amgen's patents were invalid for lack enablement. The involved patents, US 8,829,165 and US 8,859,741, are directed to monoclonal...

Saul Ewing LLP, a full-service national law firm, is proud to announce that the WTR 1000 – The World’s Leading Trademark Professionals has recognized Partners Darius Gambino and Sherry Flax in its 2023 edition. Now in its 13th year, the WTR 1000 directory is dedicated exclusively to identifying the...